In this study, we detected an inverse expression pattern between miR-17-5p and ATF3 in GC tissues and verified that ATF3 was a direct target of miR-17-5p, showing that the miR-17-5p inhibitor could promote ATF3 expression in GC cells. The gene discussed is ATF3; the disease is gastric cancer.